Aurinia Pharmaceuticals Inc.
- ISIN
- CA05156V1022
- CUSIP
- 05156V102
- Sector
- Healthcare
- Industry
- Biotechnology
AUPHPrice Chart
Click Calculate to get results
AUPHPerformance
The chart shows the growth of $10,000 invested in AUPH on Sep 4, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $32,000 for a total return of roughly 220.00%. All prices are adjusted for splits and dividends.
AUPHReturns in periods
| Period | Return |
|---|---|
| 1M | -6.98% |
| YTD | -7.45% |
| 6M | -18.37% |
| 1Y | -15.68% |
| 5Y | 33.76% |
| 10Y | 19.30% |
AUPHMonthly Returns Heatmap
Click Calculate to get results
AUPHDividends
AUPH doesn't pay dividends
AUPHDrawdowns Chart
AUPHWorst Drawdowns
The table below shows the maximum drawdowns of the Aurinia Pharmaceuticals Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the {{portfolioName}} is 67.17%, recorded on Jan 19, 2016. It took 284 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.17% | Mar 24, 2015 | 208 | Jan 19, 2016 | 284 | Mar 6, 2017 | 492 |
| -63.19% | Mar 14, 2017 | 652 | Oct 14, 2019 | 37 | Dec 5, 2019 | 689 |
| -47.16% | Jan 3, 2020 | 52 | Mar 18, 2020 | — | — | — |
| -27.75% | Sep 4, 2014 | 29 | Oct 14, 2014 | 11 | Oct 29, 2014 | 40 |
| -17.5% | Oct 30, 2014 | 14 | Nov 18, 2014 | 7 | Nov 28, 2014 | 21 |
| -17.28% | Dec 1, 2014 | 42 | Jan 30, 2015 | 18 | Feb 26, 2015 | 60 |
| -8.49% | Mar 3, 2015 | 6 | Mar 10, 2015 | 5 | Mar 17, 2015 | 11 |
| -5.51% | Dec 30, 2019 | 1 | Dec 30, 2019 | 2 | Jan 2, 2020 | 3 |
| -3.03% | Dec 18, 2019 | 1 | Dec 18, 2019 | 3 | Dec 23, 2019 | 4 |
| -1.14% | Dec 12, 2019 | 1 | Dec 12, 2019 | 1 | Dec 13, 2019 | 2 |
AUPHVolatility Chart
Current Aurinia Pharmaceuticals Inc. volatility is 30.49%. The chart below displays rolling 10-day Close-to-Close volatility.
Portfolios with Aurinia Pharmaceuticals Inc.
Loading data...